APOL1 and chronic kidney disease: Proteomic studies continue to advance, using increasingly refined techniques to analyze APOL1 isoforms, their receptors, metabolites, agonists, and potential blockers.<h4>Conclusion</h4>Risk variants have a significant impact on the understanding of CKD and kidney transplantation.